PetMed Express (Nasdaq: PETS) reported earnings on May 7. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended March 31 (Q4), PetMed Express beat expectations on revenues and earnings per share.

Compared to the prior-year quarter, revenue increased and GAAP earnings per share grew.

Margins shrank across the board.

Revenue details
PetMed Express booked revenue of $55.9 million. The six analysts polled by S&P Capital IQ expected to see sales of $52.2 million on the same basis. GAAP reported sales were 9.8% higher than the prior-year quarter's $50.9 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.20. The seven earnings estimates compiled by S&P Capital IQ anticipated $0.18 per share. GAAP EPS of $0.20 for Q4 were 11% higher than the prior-year quarter's $0.18 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 33.9%, 40 basis points worse than the prior-year quarter. Operating margin was 11.2%, 150 basis points worse than the prior-year quarter. Net margin was 7.1%, 100 basis points worse than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $75.3 million. On the bottom line, the average EPS estimate is $0.24.

Next year's average estimate for revenue is $239.5 million. The average EPS estimate is $0.77.

Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 859 members out of 888 rating the stock outperform, and 29 members rating it underperform. Among 210 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 201 give PetMed Express a green thumbs-up, and nine give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on PetMed Express is underperform, with an average price target of $11.

While many retailers continue to struggle in these tough economic times, a select few are changing the face of the business, and reaping outsize rewards. Is PetMed Express the right stock for you? Read "The Death of Wal-Mart: The Real Cash Kings Changing the Face of Retail" and decide. Click here for instant access to this free report.